がん原遺伝子タンパク質の世界市場レポート2025年

mycがん原遺伝子タンパク質の市場規模は、今後数年間で急成長が見込まれます。2029年にはCAGR12.7％で30億6,000万米ドルに成長します。このような将来の成長は、標的がん治療への注目の高まり、腫瘍学研究への資金提供の増加、個別化医療への需要の高まり、myc阻害剤の臨床試験の拡大、高度なシークエンシング技術へのアクセスの拡大などからもたらされると予測されます。予測期間中に予想される主な動向としては、遺伝子発現解析技術の進歩、ドラッグデリバリーシステムの革新、バイオマーカー探索における人工知能の利用、ペプチドベースの治療薬の調査、腫瘍学研究におけるマルチオミクスプラットフォームの採用などが挙げられます。

臨床試験の増加は、今後がん原遺伝子タンパク質市場の成長を促進すると予想されます。臨床試験とは、新しい治療や介入の安全性や有効性を評価するために、ヒトを対象として行われる調査研究です。効果的な治療法の開発を加速し、確実な安全性データを作成し、革新的な治療法をより迅速に患者に提供することを目指す研究者や企業によって、臨床試験の量が増加しています。これらの臨床試験は、有効性、安全性、耐性メカニズムを評価することで、MYCプロトオンコジーンに起因するがんに対する標的治療の評価に役立ち、MYC阻害剤や併用療法の開発の指針となっています。例えば2025年6月、米国を拠点とする科学研究の国際的リソースであるNational Center for Biotechnology Informationによると、登録された調査件数は2022年の43万7,497件から2024年には52万885件に増加しました。したがって、臨床試験数の増加ががん原遺伝子タンパク質市場の成長を牽引しています。

がんの有病率の増加は、がん原遺伝子タンパク質市場の今後の成長を促進すると予想されます。がんは、細胞が制御不能に増殖し、他の組織に侵入する可能性がある状態です。がん患者数の増加は、高齢者がこの疾患を発症しやすくなることから、高齢化社会が主な原因となっています。がんはMYCタンパク質と強く関連しており、その過剰発現は腫瘍で頻繁に観察されるため、有効な治療法開発の有望なターゲットとなっています。例えば、スイスに本部を置く政府間機関である世界保健機関（WHO）によると、2024年2月の時点で、2050年までに新たに発生するがん患者は3,500万人を超えると予測されており、2022年の推定患者数2,000万人と比べて77％の増加となっています。したがって、がんの有病率の増加ががん原遺伝子タンパク質市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のがん原遺伝子タンパク質：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のがん原遺伝子タンパク質市場：成長率分析
• 世界のがん原遺伝子タンパク質市場の実績：規模と成長, 2019-2024
• 世界のがん原遺伝子タンパク質市場の予測：規模と成長, 2024-2029, 2034F
• 世界のがん原遺伝子タンパク質：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のがん原遺伝子タンパク質市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• 組み換えタンパク質
• ポリメラーゼ連鎖反応（PCR）キット
• 酵素免疫測定（ELISA）キット
• 世界のがん原遺伝子タンパク質市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• BGA-003
• ES-4000
• ガラルミン
• その他のタイプ
• 世界のがん原遺伝子タンパク質市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子発現プロファイリング
• クロマチン免疫沈降シーケンス（ChIP-Seq）
• 次世代シーケンシング（NGS）
• リボ核酸干渉法
• 世界のがん原遺伝子タンパク質市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん調査
• 診断
• 治療の開発
• バイオマーカーの発見
• 世界のがん原遺伝子タンパク質市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術調査機関
• バイオテクノロジー企業
• 製薬会社
• 病院および診断検査室
• 世界のがん原遺伝子タンパク質市場モノクローナル抗体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療用モノクローナル抗体
• 診断用モノクローナル抗体
• 研究グレードのモノクローナル抗体
• 世界のがん原遺伝子タンパク質市場組換えタンパク質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換えMycタンパク質
• 組み換え融合タンパク質
• 組み換え抗体断片
• 世界のがん原遺伝子タンパク質市場ポリメラーゼ連鎖反応（PCR）キットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量PCR（Qpcr）キット
• 逆転写PCR（Rt-PCR）キット
• デジタルPCRキット
• 世界のがん原遺伝子タンパク質市場酵素免疫測定（ELISA）キットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• サンドイッチELISAキット
• 競合ELISAキット
• 間接ELISAキット

第7章 地域別・国別分析

• 世界のがん原遺伝子タンパク質市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のがん原遺伝子タンパク質市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん原遺伝子タンパク質市場：競合情勢
• がん原遺伝子タンパク質市場：企業プロファイル
  • Arvinas Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Arrakis Therapeutics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • RayBiotech Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Erasca Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Anima Biotech Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• RDP Pharma AG
• Peptomyc Sociedad Limitada
• Kintor Pharmaceutical Limited
• Immunostep Biotech
• Cothera Bioscience Proprietary Limited
• Escend Pharmaceuticals Incorporated
• Gibson Oncology Limited Liability Company
• MecRx Proprietary Limited
• Moleculin Biotech Incorporated
• Escend Pharmaceuticals Incorporated
• Linnane Pharma Aktiebolag
• PYC Therapeutics Limited
• Sapience Therapeutics Incorporated
• Peptomyc Sociedad Limitad
• Aptose Biosciences Incorporated

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• がん原遺伝子タンパク質市場2029：新たな機会を提供する国
• がん原遺伝子タンパク質市場2029：新たな機会を提供するセグメント
• がん原遺伝子タンパク質市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The Myc proto-oncogene protein is a transcription factor that plays a vital role in cell cycle progression, apoptosis, and cellular transformation. It is encoded by the myc gene and regulates the expression of numerous genes involved in cell growth and proliferation. Abnormal overexpression or mutation of myc is linked to the development of various cancers.

The primary product types in the Myc proto-oncogene protein market include monoclonal antibodies, recombinant proteins, polymerase chain reaction (PCR) kits, and enzyme-linked immunosorbent assay (ELISA) kits. Monoclonal antibodies are laboratory-generated proteins that are identical copies of a single antibody, specifically designed to bind to a unique antigen, helping the immune system target and destroy specific cells or substances. Key types include BGA-003, ES-4000, Galarmin, and others. The technologies employed in this field include gene expression profiling, chromatin immunoprecipitation sequencing (ChIP-Seq), next-generation sequencing (NGS), and RNA interference techniques. These products are applied in cancer research, diagnostics, treatment development, and biomarker discovery, serving crucial needs in oncology and molecular biology. The primary end-users include academic and research institutions, biotechnology companies, pharmaceutical firms, and hospitals and diagnostic laboratories.

The myc proto oncogene protein market research report is one of a series of new reports from The Business Research Company that provides myc proto oncogene protein market statistics, including the myc proto oncogene protein industry global market size, regional shares, competitors with the myc proto oncogene protein market share, detailed myc proto oncogene protein market segments, market trends, and opportunities, and any further data you may need to thrive in the myc proto oncogene protein industry. This myc proto oncogene protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myc proto-oncogene protein market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.90 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. Growth during the historical period was driven by the rising global incidence of cancer, greater adoption of biomarker-based diagnostics, increased academic research into transcription factors, expansion of oncology drug discovery efforts, and growing use of monoclonal antibodies in cancer detection.

The myc proto-oncogene protein market size is expected to see rapid growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. This future growth is anticipated to result from a heightened focus on targeted cancer therapies, increased funding for oncology research, a growing demand for personalized medicine, expanding clinical trials for myc inhibitors, and wider access to advanced sequencing technologies. Key trends expected during the forecast period include advances in gene expression analysis technologies, innovations in drug delivery systems, the use of artificial intelligence in biomarker discovery, research into peptide-based therapeutics, and the adoption of multi-omics platforms in oncology research.

The increasing number of clinical trials is expected to propel the growth of the myc proto oncogene protein market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments or interventions. The growing volume of clinical trials is driven by researchers and companies aiming to accelerate the development of effective therapies, generate robust safety data, and deliver innovative treatments to patients more quickly. These trials help assess targeted therapies against myc proto-oncogene-driven cancers by evaluating efficacy, safety, and resistance mechanisms, thereby guiding the development of MYC inhibitors and combination treatments. For instance, in June 2025, according to the National Center for Biotechnology Information, a US-based international resource for scientific research, the number of registered studies rose from 437,497 in 2022 to 520,885 in 2024. Therefore, the increasing number of clinical trials is driving the growth of the myc proto oncogene protein market.

The increasing prevalence of cancer is expected to propel the growth of the myc proto oncogene protein market going forward. Cancer is a condition in which cells multiply uncontrollably and may invade other tissues. The rising number of cancer cases is largely attributed to an aging population, as older individuals are more susceptible to developing the disease. Cancer is strongly linked to the MYC protein, whose overexpression is frequently observed in tumors, making it a promising target for the development of effective therapies. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, more than 35 million new cancer cases were projected by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the myc proto oncogene protein market.

Major companies operating in the myc proto oncogene protein market are increasingly focusing on advanced therapeutics, such as myc-targeting peptide therapeutics, to revolutionize cancer treatment. A myc-targeting peptide therapeutic is a novel class of drug developed to inhibit the myc oncogene, which is abnormally activated in the majority of cancers and plays a key role in tumor growth and progression. For instance, in January 2025, Peptomyc S.L., a Spain-based biotechnology company, initiated a new Phase 2 clinical trial for its myc-inhibitor drug OMO-103 in patients with advanced osteosarcoma. OMO-103 is a first-in-class myc-targeting peptide designed to disrupt myc function in cancer cells, demonstrating a manageable safety profile and notable anti-tumor activity. This trial aims to evaluate the drug's clinical efficacy, safety, and pharmacodynamics, representing a significant advancement in targeted therapies for hard-to-treat cancers such as osteosarcoma.

Major players in the myc proto oncogene protein market are Arvinas Incorporated, Arrakis Therapeutics Incorporated, RayBiotech Incorporated, Erasca Incorporated, Anima Biotech Incorporated, RDP Pharma AG, Peptomyc Sociedad Limitada, Kintor Pharmaceutical Limited, Immunostep Biotech, Cothera Bioscience Proprietary Limited, Escend Pharmaceuticals Incorporated, Gibson Oncology Limited Liability Company, MecRx Proprietary Limited, Moleculin Biotech Incorporated, Escend Pharmaceuticals Incorporated, Linnane Pharma Aktiebolag, PYC Therapeutics Limited, Sapience Therapeutics Incorporated, Peptomyc Sociedad Limitad, and Aptose Biosciences Incorporated.

North America was the largest region in the myc proto oncogene protein market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myc proto oncogene protein report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the myc proto oncogene protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myc proto oncogene protein market consists of sales of inhibitors, modulators, antibodies, and ribonucleic acid-based therapeutics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myc Proto Oncogene Protein Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myc proto oncogene protein market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myc proto oncogene protein ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The myc proto oncogene protein market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Monoclonal Antibodies; Recombinant Proteins; Polymerase Chain Reaction (PCR) Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits
• 2) By Type: BGA-003; ES-4000; Galarmin; Other Types
• 3) By Technology: Gene Expression Profiling; Chromatin Immunoprecipitation Sequencing (ChIP-Seq); Next-Generation Sequencing (NGS); Ribonucleic Acid Interference Techniques
• 4) By Application: Cancer Research; Diagnostics; Treatment Development; Biomarker Discovery
• 5) By End-User: Academic And Research Institutions; Biotechnology Companies; Pharmaceutical Companies; Hospitals And Diagnostic Laboratories
• Subsegments:
• 1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies; Research-Grade Monoclonal Antibodies
• 2) By Recombinant Proteins: Recombinant Myc Proteins; Recombinant Fusion Proteins; Recombinant Antibody Fragments
• 3) By Polymerase Chain Reaction (PCR) Kits: Quantitative PCR (Qpcr) Kits; Reverse Transcription PCR (Rt-Pcr) Kits; Digital PCR Kits
• 4) By Enzyme-Linked Immunosorbent Assay (ELISA) Kits: Sandwich ELISA Kits; Competitive ELISA Kits; Indirect ELISA Kits
• Companies Mentioned: Arvinas Incorporated; Arrakis Therapeutics Incorporated; RayBiotech Incorporated; Erasca Incorporated; Anima Biotech Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myc Proto Oncogene Protein Market Characteristics

3. Myc Proto Oncogene Protein Market Trends And Strategies

4. Myc Proto Oncogene Protein Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Myc Proto Oncogene Protein Growth Analysis And Strategic Analysis Framework

• 5.1. Global Myc Proto Oncogene Protein PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Myc Proto Oncogene Protein Market Growth Rate Analysis
• 5.4. Global Myc Proto Oncogene Protein Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Myc Proto Oncogene Protein Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Myc Proto Oncogene Protein Total Addressable Market (TAM)

6. Myc Proto Oncogene Protein Market Segmentation

• 6.1. Global Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Recombinant Proteins
• Polymerase Chain Reaction (PCR) Kits
• Enzyme-Linked Immunosorbent Assay (ELISA) Kits
• 6.2. Global Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BGA-003
• ES-4000
• Galarmin
• Other Types
• 6.3. Global Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Expression Profiling
• Chromatin Immunoprecipitation Sequencing (ChIP-Seq)
• Next-Generation Sequencing (NGS)
• Ribonucleic Acid Interference Techniques
• 6.4. Global Myc Proto Oncogene Protein Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Research
• Diagnostics
• Treatment Development
• Biomarker Discovery
• 6.5. Global Myc Proto Oncogene Protein Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutions
• Biotechnology Companies
• Pharmaceutical Companies
• Hospitals And Diagnostic Laboratories
• 6.6. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Monoclonal Antibodies
• Diagnostic Monoclonal Antibodies
• Research-Grade Monoclonal Antibodies
• 6.7. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Myc Proteins
• Recombinant Fusion Proteins
• Recombinant Antibody Fragments
• 6.8. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR) Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative PCR (Qpcr) Kits
• Reverse Transcription PCR (Rt-Pcr) Kits
• Digital PCR Kits
• 6.9. Global Myc Proto Oncogene Protein Market, Sub-Segmentation Of Enzyme-Linked Immunoassay (ELISA) Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sandwich ELISA Kits
• Competitive ELISA Kits
• Indirect ELISA Kits

7. Myc Proto Oncogene Protein Market Regional And Country Analysis

• 7.1. Global Myc Proto Oncogene Protein Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Myc Proto Oncogene Protein Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myc Proto Oncogene Protein Market

• 8.1. Asia-Pacific Myc Proto Oncogene Protein Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myc Proto Oncogene Protein Market

• 9.1. China Myc Proto Oncogene Protein Market Overview
• 9.2. China Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myc Proto Oncogene Protein Market

• 10.1. India Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myc Proto Oncogene Protein Market

• 11.1. Japan Myc Proto Oncogene Protein Market Overview
• 11.2. Japan Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myc Proto Oncogene Protein Market

• 12.1. Australia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myc Proto Oncogene Protein Market

• 13.1. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myc Proto Oncogene Protein Market

• 14.1. South Korea Myc Proto Oncogene Protein Market Overview
• 14.2. South Korea Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myc Proto Oncogene Protein Market

• 15.1. Western Europe Myc Proto Oncogene Protein Market Overview
• 15.2. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myc Proto Oncogene Protein Market

• 16.1. UK Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myc Proto Oncogene Protein Market

• 17.1. Germany Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myc Proto Oncogene Protein Market

• 18.1. France Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myc Proto Oncogene Protein Market

• 19.1. Italy Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myc Proto Oncogene Protein Market

• 20.1. Spain Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myc Proto Oncogene Protein Market

• 21.1. Eastern Europe Myc Proto Oncogene Protein Market Overview
• 21.2. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myc Proto Oncogene Protein Market

• 22.1. Russia Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myc Proto Oncogene Protein Market

• 23.1. North America Myc Proto Oncogene Protein Market Overview
• 23.2. North America Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myc Proto Oncogene Protein Market

• 24.1. USA Myc Proto Oncogene Protein Market Overview
• 24.2. USA Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myc Proto Oncogene Protein Market

• 25.1. Canada Myc Proto Oncogene Protein Market Overview
• 25.2. Canada Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myc Proto Oncogene Protein Market

• 26.1. South America Myc Proto Oncogene Protein Market Overview
• 26.2. South America Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myc Proto Oncogene Protein Market

• 27.1. Brazil Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myc Proto Oncogene Protein Market

• 28.1. Middle East Myc Proto Oncogene Protein Market Overview
• 28.2. Middle East Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myc Proto Oncogene Protein Market

• 29.1. Africa Myc Proto Oncogene Protein Market Overview
• 29.2. Africa Myc Proto Oncogene Protein Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Myc Proto Oncogene Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Myc Proto Oncogene Protein Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myc Proto Oncogene Protein Market Competitive Landscape And Company Profiles

• 30.1. Myc Proto Oncogene Protein Market Competitive Landscape
• 30.2. Myc Proto Oncogene Protein Market Company Profiles
  • 30.2.1. Arvinas Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Arrakis Therapeutics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. RayBiotech Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Erasca Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Anima Biotech Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Myc Proto Oncogene Protein Market Other Major And Innovative Companies

• 31.1. RDP Pharma AG
• 31.2. Peptomyc Sociedad Limitada
• 31.3. Kintor Pharmaceutical Limited
• 31.4. Immunostep Biotech
• 31.5. Cothera Bioscience Proprietary Limited
• 31.6. Escend Pharmaceuticals Incorporated
• 31.7. Gibson Oncology Limited Liability Company
• 31.8. MecRx Proprietary Limited
• 31.9. Moleculin Biotech Incorporated
• 31.10. Escend Pharmaceuticals Incorporated
• 31.11. Linnane Pharma Aktiebolag
• 31.12. PYC Therapeutics Limited
• 31.13. Sapience Therapeutics Incorporated
• 31.14. Peptomyc Sociedad Limitad
• 31.15. Aptose Biosciences Incorporated

32. Global Myc Proto Oncogene Protein Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myc Proto Oncogene Protein Market

34. Recent Developments In The Myc Proto Oncogene Protein Market

35. Myc Proto Oncogene Protein Market High Potential Countries, Segments and Strategies

• 35.1 Myc Proto Oncogene Protein Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Myc Proto Oncogene Protein Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Myc Proto Oncogene Protein Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer